MORE►
Invention
[Image: Shutterstock]
Get on the List: Explore the Future of North Texas in Dallas Innovates Magazine
by Dallas Innovates | Staff Report | Jan 17, 2023
Don't miss your chance to get our biggest-ever Dallas Innovates magazine. Request a complimentary copy of the once-a-year limited edition now.
by Dallas Innovates | Staff Report |
Jan 15, 2023
Dallas Invents is a weekly look at U.S. patents granted with a connection to the Dallas-Fort Worth-Arlington metro area. Listings include patents granted to local assignees and/or those with a North Texas inventor. Patent activity can be an indicator of future economic growth, as well as the development of emerging markets and talent attraction. ...
MORE►
by Lance Murray |
Jan 11, 2023
The collaboration has led to an innovative VR training tool that places physicians inside a virtual hospital examination room—where they experience a series of realistic patient encounters. The tool enables physicians to practice proven de-escalation tactics to help these incidents end peacefully.
MORE►
by Dallas Innovates | Staff Report |
Jan 10, 2023
Dallas Invents is a weekly look at U.S. patents granted with a connection to the Dallas-Fort Worth-Arlington metro area. Listings include patents granted to local assignees and/or those with a North Texas inventor. Patent activity can be an indicator of future economic growth, as well as the development of emerging markets and talent attraction. ...
MORE►
Dallas Invents: 90 Patents Granted for Week of December 20
by Dallas Innovates | Staff Report | Jan 8, 2023
Dallas Invents is a weekly look at U.S. patents granted with a connection to the Dallas-Fort Worth-Arlington metro area. Listings include patents granted to local assignees and/or those with a North Texas inventor. Patent activity can be an indicator of future economic growth, as well as the development of emerging markets and talent attraction. ...
MORE►
by Dallas Innovates | Staff Report |
Jan 7, 2023
Dallas Invents is a weekly look at U.S. patents granted with a connection to the Dallas-Fort Worth-Arlington metro area. Listings include patents granted to local assignees and/or those with a North Texas inventor. Patent activity can be an indicator of future economic growth, as well as the development of emerging markets and talent attraction. ...
MORE►
by Dallas Innovates | Staff Report |
Jan 6, 2023
Dallas Invents is a weekly look at U.S. patents granted with a connection to the Dallas-Fort Worth-Arlington metro area. Listings include patents granted to local assignees and/or those with a North Texas inventor. Patent activity can be an indicator of future economic growth, as well as the development of emerging markets and talent attraction. ...
MORE►
by Quincy Preston |
Dec 28, 2022
Dallas-Fort Worth ranked No. 10 for patents out of 250 metros. Patents granted include: Akamai Technologies' device discovery for cloud-based network security gateways, Amazon's identity-aware filtering proxy for virtual networks, BMIC's asphalt shingle waste coatings in roofing materials, Capital One's sorted parallel processing of a large dataset, EarthSystems Technologies' predictive monitoring geological and meteorological effects on subsurface infrastructure systems and reporting emergency conditions, Google's methods and computer program products for providing data use options, Halliburton's sealing apparatus with swellable metal, Toyota's managing drones in vehicular system, USAA's voice synthesis for virtual agents, and more.
MORE►
Michael Vasilyev, a professor of electrical engineering at the University of Texas at Arlington, has been awarded an $800,000 grant by the National Science Foundation to lead a project expanding research and education in quantum information science and engineering. [Photo: UTA]
Quantum Leap: UT Arlington’s $800K Research Project Pushes Boundaries in Quantum Science and Engineering
by Lance Murray | Dec 22, 2022
The highly competitive grant shows NSF’s willingness to expand the study of quantum information technology to universities that are aspiring to become major players in the field, said UTA professor Michael Vasilyeve, who will lead the project.
One purpose of the NSF's expansion program is to ensure a steady supply of skilled workers for the quantum information technology industry, which is constantly in need of more talent than is available.
One purpose of the NSF's expansion program is to ensure a steady supply of skilled workers for the quantum information technology industry, which is constantly in need of more talent than is available.
MORE►
by Quincy Preston |
Dec 22, 2022
The Dallas-based biopharmaceutical company expects to begin testing the drug candidate in a “first in human” trial in mid-2023. The drug was developed using the publicly traded company’s AI/ML drug development platform.
Lantern, in collaboration with the National Cancer Institute, recently published insights on how AI can be used to find new indications for cancer drugs in record times with significant reductions in costs.
Lantern, in collaboration with the National Cancer Institute, recently published insights on how AI can be used to find new indications for cancer drugs in record times with significant reductions in costs.
MORE►
by Lance Murray |
Dec 21, 2022
UT Southwestern researchers have used gene editing technology to develop what could be a breakthrough for dilated cardiomyopathy, a heart condition that affects one in 250 people worldwide.
“The pace of this field is really breathtaking,” said Eric Olson, Ph.D., who co-led the study. “I expect that if this moves forward into patients, we’re not talking within decades—we’re talking within years.”
MORE►
by Quincy Preston |
Dec 21, 2022
Dallas-Fort Worth ranked No. 10 for patents out of 250 metros. Patents granted include: Aon Risk Services' digital property collateral protection, Capitalogix's advanced systems and methods for allocating capital to trading strategies for big data trading in financial markets, Dell Products' detection of indicators of attack, Nallen Holdings' paint removal unit, USAA's appliance monitoring sensors, and more.
MORE►
[Source image: istockphoto]
Taysha Gene Therapies Replaces CEO, Appoints R&D Chief
by Quincy Preston | Dec 19, 2022
Dallas-based Taysha Gene Therapies is starting a new chapter in its fight to tackle devastating neurological conditions with changes in its top executive leadership.
Late Friday, the publicly traded biotech announced that Sean P. Nolan, the current chair of the board of directors and an experienced biopharmaceutical industry leader, is the company’s new CEO....
MORE►
by Quincy Preston and David Seeley |
Dec 19, 2022
Co-founders Paul Stewart and Frank Murdock started up SkinStasis Skin Care earlier this year to meet "a big unmet need" in the cold sore/herpes virus field, where they say there's been "no real new pharmaceutical development" for over 20 years.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
MORE►
by Kevin Cummings |
Dec 16, 2022
Carmack—the former CTO of VR giant Oculus—has taken goggle-gazing to the next level, programmed Doom and Quake, and founded a Mesquite-based space tourism startup. Now he's on a mission he says "could change the course of human history": artificial general intelligence. Keen's focus on AGI could lead to "something that behaves like a human being or like a living creature, and that can then be educated in whatever ways that we need to," he says.
Carmack believes AGI will hit the market in less than a decade. enabling AIs to interact socially with each other—or with actual people.
Carmack believes AGI will hit the market in less than a decade. enabling AIs to interact socially with each other—or with actual people.
MORE►
by Lance Murray |
Dec 15, 2022
The United States Patent and Trademark Office has announced the new Cancer Moonshot Expedited Examination Pilot Program, in an effort to accelerate innovation in the health and medical fields....
MORE►
